[1] Ultrastructural changes of peritoneal lining cells in uremia.

[2] [Changes in peritoneal mesothelial cells in patients on peritoneal dialysis].

[3] A Bifunctional Adsorber Particle for the Removal of Hydrophobic Uremic Toxins from Whole Blood of Renal Failure Patients.

[4] An Atypical Case of Shiga Toxin Producing-Escherichia Coli Hemolytic and Uremic Syndrome (STEC-HUS) in a Lung Transplant Recipient

[5] The Association Between Idiopathic Hemolytic Uremic Syndrome and Infection by Verotoxin-Producing Escherichia coli

[6] Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis

[7] The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

[8] Risk of Hemolytic Uremic Syndrome After Antibiotic Treatment of Escherichia coli O157:H7 Enteritis: A Meta-analysis

[9] uremic cardiomyopathy: a new piece in the chronic kidney disease-mineral and bone disorder puzzle

[10] bilateral stenosis of renal arteries in a patient with primary antiphospholipid syndrome following hemolyticouremic syndrome (a case report and review of literature)

[11] critical appraisal of eculizumab for atypical hemolytic uremic syndrome

[12] surgical complications of hemolytic uremic syndrome: single center experiences

[13] chorea due to basal ganglia involvement in a uremic diabetic patient

[14] postoperative atypical hemolytic uremic syndrome associated with complement c3 mutation

[15] eculizumab therapy leads to rapid resolution of thrombocytopenia in atypical hemolytic uremic syndrome

[16] uremic pruritus is not associated with endocannabinoid receptor 1 gene polymorphisms

[17] atypical hemolytic uremic syndrome post kidney transplantation: two case reports and review of the literature

[18] actualización en síndrome hemolítico urémico atípico: diagnóstico y tratamiento. documento de consenso

[19] frecuencia de secuela renal pos evento agudo en síndrome urémico hemolítico

[20] nicorandil-induced hyperkalemia in a uremic patient

[21] uremic toxins enhance statin-induced cytotoxicity in differentiated human rhabdomyosarcoma cells

[22] indolic uremic solutes enhance procoagulant activity of red blood cells through phosphatidylserine exposure and microparticle release

[23] hemorrhagic retinopathy in an infant with hemolytic-uremic syndrome

[24] dialysis water treated by reverse osmosis decreases the levels of c-reactive protein in uremic patients